Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Anyone seeking a regulated medical treatment BPC-157 is not an FDA-approved drug
Very pleased with this business & the level of service they provide
This needs medical attention, not watchful waiting
The announcement was widely interpreted as a signal that the FDA under the new administration would take a more permissive stance toward peptide compounding than the 2023 Pharmacy Compounding Advisory Committee position, which had placed BPC-157 firmly in Category 2 (substances the FDA had concerns about for compounding use)
It regulates cytokines (TNF-, IL-6), decreases swelling, and limits immune-cell overactivity
These peptides can interact chemically when mixed together, potentially degrading potency
US$ 25.19
US$ 28.64
US$ 25.97
US$ 27.32
US$ 20.64
